1. JAK/STAT Signaling Protein Tyrosine Kinase/RTK Cell Cycle/DNA Damage Apoptosis
  2. EGFR CDK Apoptosis Caspase Bcl-2 Family
  3. EGFR/CDK2-IN-5

EGFR/CDK2-IN-5 是一种强效的 EGFRCDK2 双重抑制剂,其 IC50 值分别为 17.30 nM 和 212.10 nM。EGFR/CDK2-IN-5 还能抑制 EGFRT790MIC50 值为 123.8 nM。EGFR/CDK2-IN-5 具有显著的抗癌活性。EGFR/CDK2-IN-5 可诱导 G1 期和 S 期细胞周期阻滞和细胞凋亡 (apoptosis),并伴有 caspase-3/9Bax 水平升高以及 Bcl-2 水平降低。EGFR/CDK2-IN-5 可用于肺癌、乳腺癌和白血病等癌症的研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

EGFR/CDK2-IN-5

EGFR/CDK2-IN-5 Chemical Structure

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

EGFR/CDK2-IN-5 is a potent dual EGFR and CDK2 inhibitor with IC50s of 17.30 and 212.10 nM, respectively. EGFR/CDK2-IN-5 also inhibits EGFRT790M with an IC50 of 123.8 nM. EGFR/CDK2-IN-5 exhibits potent anticancer activity. EGFR/CDK2-IN-5 induces G1 and S cell cycle arrest and apoptosis, accompanied by increased levels of caspase-3/9 and Bax, as well as decreased Bcl-2 levels. EGFR/CDK2-IN-5 can be used for the research of cancers, such as lung cancer, breast cancer, and leukemia[1].

IC50 & Target[1]

CDK2

212.10 nM (IC50)

EGFR

17.30 nM (IC50)

EGFRT790M

123.8 nM (IC50)

Caspase-9

 

Caspase-3

 

Bcl-2

 

Bax

 

体外研究
(In Vitro)

EGFR/CDK2-IN-5 (compound 7c) (48 小时) 在多种癌细胞中表现出广谱活性,对 HCT-116 和 LOX-IMVI 细胞的活性强,IC50 值分别为 11.3 和 20.03 μM,而对正常细胞 WI-38 和 Vero 细胞的细胞毒性较低 (IC50 > 50 μM)[1]
EGFR/CDK2-IN-5 (11.3-20.03 μM,24 小时) 在 HCT-116 中引起 G1 期阻滞,在 LOX-IMVI 中引起 S 期阻滞,并诱导两种细胞发生凋亡[1]
EGFR/CDK2-IN-5 (5.65 μM,24 小时) 在 HCT-116 细胞中降低了 EGFR、pEGFR、pCDK2 和 CDK2 蛋白的表达[1]
EGFR/CDK2-IN-5 (11.3 μM,48 h) 可增加 HCT-116 细胞中 caspase-3/9 和 Bax 的基因表达水平以及 BAX/Bcl-2 比率,同时降低 Bcl-2 的基因表达水平[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Cycle Analysis[1]

Cell Line: HCT-116, LOX-IMVI
Concentration: 11.3 μM (HCT-116), 20.03 μM (LOX-IMVI)
Incubation Time: 24 h
Result: Caused G1 phase arrest in HCT-116 and S phase arrest in LOX-IMVI.

Western Blot Analysis[1]

Cell Line: HCT-116
Concentration: 5.65 μM
Incubation Time: 24 h
Result: Reduced the expression of EGFR, pEGFR, CDK2, and pCDK2 in HCT-116 cells.

Apoptosis Analysis[1]

Cell Line: HCT-116, LOX-IMVI
Concentration: 11.3 μM (HCT-116), 20.03 μM (LOX-IMVI)
Incubation Time: 24 h
Result: Induced apoptosis in n HCT-116 and LOX-IMVI cells.

RT-PCR[1]

Cell Line: HCT-116
Concentration: 11.3 μM
Incubation Time: 48 h
Result: Increased the mRNA levels of Bax, caspase-3, and caspase-9.
Increased BAX/Bcl-2 ratio.
Decreased Bcl-2 mRNA levels.
分子量

508.61

Formula

C31H32N4O3

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
EGFR/CDK2-IN-5
目录号:
HY-180242
需求量: